$ADIL Balance Sheet | Understand Stock

$ADIL

$3.71 +$0.03 (0.82%) Close

$ADIL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
ASSETS
Current Assets:
Purnovate sale payments receivable
Prepaid research and development
Cash and cash equivalents
Prepaid expenses and other current assets
Current assets of discontinued operations
Total Current Assets

Research and development supplies
Fixed Assets, net
Acquired in-process research and development
Right-to-use Asset
Goodwill
Intangible assets, net
Equity method investment
Assets of discontinued operations
Total Assets

LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current Liabilities:
Accounts payable
Accounts payable, related party
Related Party
Total accounts payable, related party
Accrued expenses
Lease liability, current
Accrued expenses, related party
Related Party
Total accrued expenses, related party

Current liabilities of discontinued operations
Total Current Liabilities
Lease liability, net of current portion

Contingent liabilities
Lease liability, non-current

Deferred tax liability
Long-term liabilities of discontinued operations
Milestone warrant rights liability
Total Liabilities
Series A convertible preferred stock, $0.001 par value; 13,000 and 0 shares designated as of June 30, 2026 and December 31, 2025, respectively; 12,930.617 and 0 shares issued and outstanding as of June 30 2026 and December 31, 2025, respectively
Stockholders’ (Deficit) Equity
Common Stock, 100,000,000 shares authorized with a par value of $0.001 per share, 2,625,890 and 1,111,010 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Additional paid in capital
Accumulated deficit
Total Stockholders’ (Deficit) Equity
Total Liabilities, Temporary Equity and Stockholders’ (Deficit) Equity

Comments